Author:
de la Espriella Rafael,Miñana Gema,Santas Enrique,Núñez Gonzalo,Lorenzo Miguel,Núñez Eduardo,Bayés-Genís Antoni,Núñez Julio
Funder
Center for International Business Education and Research, University of Illinois at Urbana-Champaign
CIBER
Subject
Cardiology and Cardiovascular Medicine
Reference17 articles.
1. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with Type 2 diabetes: A meta-analysis;McGuire;JAMA Cardiol.,2020
2. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials;Zannad;Lancet,2020
3. Dapagliflozin in patients with chronic kidney disease;Heerspink;N. Engl. J. Med.,2020
4. Effect of Empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: The EMPEROR-Reduced Trial;Packer;Circulation,2020
5. Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction: A prespecified analysis of DAPA-HF;Docherty;Circulation,2020
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献